Table 2.
Control | Diabetic | Control + Lr | Diabetic + Lr | |
---|---|---|---|---|
Tt.Ar. (mm2) | 2.15 ± 0.08 | 2.06 ± 0.05 | 2.20 ± 0.07 | 2.14 ± 0.06 |
Ct.Ar. (mm2) | 1.13 ± 0.05 | 0.98 ± 0.03a | 1.20 ± 0.03 | 1.16 ± 0.04b |
Ma.Ar. (mm2) | 1.02 ± 0.04 | 1.07 ± 0.03 | 1.00 ± 0.05 | 0.98 ± 0.04 |
Ct.Ar./Tt.Ar. | 0.52 ± 0.01 | 0.48 ± 0.01a | 0.55 ± 0.01 | 0.54 ± 0.01b |
Thickness (mm) | 0.26 ± 0.01 | 0.23 ± 0.01a | 0.29 ± 0.01 | 0.27 ± 0.01b |
Inner perimeter (mm) | 3.86 ± 0.06 | 3.94 ± 0.05 | 3.84 ± 0.09 | 3.80 ± 0.08b |
Outer perimeter (mm) | 5.43 ± 0.10 | 5.32 ± 0.06 | 5.56 ± 0.07 | 5.47 ± 0.09 |
MOI (mm4) | 0.58 ± 0.05 | 0.50 ± 0.03 | 0.63 ± 0.03 | 0.59 ± 0.04b |
Abbreviations: Ct.Ar, cortical bone area; Ct.Ar./Tt.Ar., cortical area fraction; Lr, L. reuteri; Ma.Ar., marrow area; MOI, the cross-sectional moments of inertia at the z-axis; Tt.Ar., total cross-sectional area. Data are averages ± SE. n = 10 per condition.
P ≤ .05 to control.
P ≤ .05 to diabetic group by one-way ANOVA.